AGPAT2 anticorps (1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta)) (FITC)

Details for Product anti-AGPAT2 Antibody No. ABIN708663
Antigène
  • AGPAT2
  • zgc:153984
  • 1-agpat2
  • bscl
  • bscl1
  • lpaab
  • lpaat-beta
  • 1-AGPAT2
  • BSCL
  • BSCL1
  • LPAAB
  • LPAAT-beta
  • 2510002J07Rik
  • AV000834
  • 1-acylglycerol-3-phosphate O-acyltransferase 2
  • 1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)
  • AGPAT2
  • agpat2
  • Agpat2
Reactivité
Humain, Souris, Rat (Rattus)
59
20
15
1
1
1
1
1
Hôte
Lapin
54
5
Clonalité
Polyclonal
Conjugué
Cet anticorp AGPAT2 est conjugé à/à la FITC
3
3
3
3
3
3
3
1
1
1
1
1
1
Application
Immunofluorescence (Paraffin-embedded Sections) (IF (p))
35
12
10
10
6
4
2
1
1
1
Options
Immunogène KLH conjugated synthetic peptide derived from human Agpat2
Isotype IgG
Purification Purified by Protein A.
Plasmids, Primers & others Plasmids, Primers & others AGPAT2 products on genomics-online (e.g. as negative or positive controls)
Antigène
Autre désignation Agpat2 (AGPAT2 Antibody Extrait)
Sujet

Agpat2 is a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. It is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in its have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.

Synonyms: LPAAB, BSCL, BSCL1, EC 2.3.1.51, LPAAB, LPAAT beta, Lysophosphatidic acid acyltransferase beta, 1 acyl sn glycerol 3 phosphate acyltransferase beta, 1 acylglycerol 3 phosphate O acyltransferase 2, 1 AGP acyltransferase 2, 1 AGPAT2 antibody Berardinelli Seip congenital lipodystrophy.PLCB_HUMAN

ID gène 10555
Indications d'application IF(IHC-P) 1:50-200
Restrictions For Research Use only
Format Liquid
Concentration 1 μg/μL
Buffer Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
Agent conservateur Sodium azide
Précaution d'utilisation This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Stock 4 °C
Stockage commentaire Store at 4°C
Date de péremption 12 months